Janssen agrees to settle two Risperdal gynecomastia cases in Philadelphia

Nov. 3, 2016 – San Diego, CA – Johnson & Johnson subsidiary Janssen Pharmaceuticals settled two lawsuits over its antipsychotic drug Risperdal last week, one just days before it was...

FDA gives green light to new Concerta generic after walking back approval of two others

Nov. 1, 2016 – San Diego, CA -- A generic version of the ADHD drug Concerta could soon be hitting the market, potentially allowing more access to cheaper versions of...

Federal judge delays Xarelto bellwether trials because of NBA All-Star games

[caption id="attachment_34634" align="aligncenter" width="434"] Courtesy of the NBA All-Star Weekend New Orleans Instagram page[/caption] Oct. 26, 2016 -- San Diego, CA -- The four cases selected to be tried first in...

Sales of J&J’s baby products down amidst high-profile talc lawsuits

Company’s third-quarter earnings show drop in baby & women’s health products, but sales of blood thinner Xarelto jump despite lawsuits Oct. 24, 2016 – San Diego, CA -- Worldwide sales...

America’s most popular drugs are overprescribed and making us sick

Oct. 21, 2016 – San Diego, CA -- One UK pharmacologist has called on doctors across the globe to stop overprescribing the popular heartburn medications proton pump inhibitors. Proton pump...

Plaintiffs ask to consolidate PPI claims into MDL

Oct. 20, 2016 – San Diego, CA -- Plaintiffs suing several pharmaceutical companies over their heartburn medications are asking the Judicial Panel on Multidistrict Litigation to consolidate their claims into...

FDA moves to pull generic Concerta from market

Makers have 30 days to call for hearing and prove drugs work the same as brand-name Oct. 20, 2016 – San Diego, CA -- The makers of two generic versions...

Zofran maker attempts to get lawsuits dismissed in three separate motions

Oct. 19, 2016 – San Diego, CA -- GlaxoSmithKline is urging a Massachusetts federal court to dismiss some or all claims lodged against the company and its anti-nausea drug Zofran,...

Janssen appeals $76M Risperdal verdict

Pharmaceutical company argues verdict was “blatantly excessive;" plaintiffs challenge court order preventing punitive damage awards Oct. 18, 2016 – San Diego, CA -- Janssen Pharmaceuticals appealed a $70 million verdict awarded...

Could FDA’s re-analysis of Xarelto study affect ongoing litigation?

Oct. 14, 2016 – San Diego, CA -- This week, the U.S. Food and Drug Administration posted the conclusion of its re-analysis of the ROCKET AF trial, which helped propel...